Details for New Drug Application (NDA): 062290
✉ Email this page to a colleague
NDA 062290 describes ERYDERM, which is a drug marketed by Arbor Pharms Inc and is included in one NDA. Additional details are available on the ERYDERM profile page.
The generic ingredient in ERYDERM is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
The generic ingredient in ERYDERM is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 062290
| Tradename: | ERYDERM |
| Applicant: | Arbor Pharms Inc |
| Ingredient: | erythromycin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 062290
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 2% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
